Published in Mol Endocrinol on February 23, 2006
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23
An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell (2007) 2.75
Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell (2008) 2.35
Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics (2006) 2.14
Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem (2009) 1.70
Estrogen signaling and cardiovascular disease. Circ Res (2011) 1.59
Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol (2008) 1.57
Nε-lysine acetylation of a bacterial transcription factor inhibits Its DNA-binding activity. PLoS One (2010) 1.44
G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. Nat Commun (2016) 1.43
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol (2009) 1.43
SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta (2009) 1.41
Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res (2010) 1.34
Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res (2008) 1.23
SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res (2011) 1.21
Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome. Mol Endocrinol (2008) 1.14
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer. Breast Cancer Res Treat (2010) 1.14
Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling. Carcinogenesis (2009) 1.11
Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites. Mol Cell Proteomics (2008) 1.11
Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy. Nucleic Acids Res (2011) 1.09
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. Elife (2014) 1.07
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305. Breast Cancer Res Treat (2009) 1.05
Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. Proc Natl Acad Sci U S A (2013) 1.05
The functional significance of nuclear receptor acetylation. Steroids (2007) 1.04
Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. J Biol Chem (2011) 1.01
Interaction of estrogen receptor alpha with proliferating cell nuclear antigen. Nucleic Acids Res (2007) 1.01
The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol Endocrinol (2010) 1.01
Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev (2012) 1.01
Mechismo: predicting the mechanistic impact of mutations and modifications on molecular interactions. Nucleic Acids Res (2014) 1.01
Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy. Cancers (Basel) (2011) 1.00
CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter. Mol Cell Biol (2011) 0.98
Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. Breast Cancer Res (2010) 0.97
Transcription factor functionality and transcription regulatory networks. Mol Biosyst (2008) 0.96
Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity. Oncogene (2010) 0.95
Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol Endocrinol (2011) 0.95
Minireview: role of protein methylation and demethylation in nuclear hormone signaling. Mol Endocrinol (2009) 0.95
Structural and functional analysis of domains of the progesterone receptor. Mol Cell Endocrinol (2011) 0.95
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding. Nucleic Acids Res (2008) 0.94
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation. BMC Mol Biol (2012) 0.94
Liganded and unliganded activation of estrogen receptor and hormone replacement therapies. Biochim Biophys Acta (2011) 0.93
Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly. Mol Cell Biol (2007) 0.93
Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues. Mol Cell Endocrinol (2010) 0.92
Acetylation in nuclear receptor signaling and the role of sirtuins. Mol Endocrinol (2007) 0.91
New Neurons in Aging Brains: Molecular Control by Small Non-Coding RNAs. Front Neurosci (2012) 0.91
Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor. Circ Res (2009) 0.90
Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol (2010) 0.89
Post-translational modifications of the progesterone receptors. J Steroid Biochem Mol Biol (2013) 0.88
Sirtuins in epigenetic regulation. Chem Rev (2015) 0.88
Emerging roles of lysine methylation on non-histone proteins. Cell Mol Life Sci (2015) 0.87
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? J Biomed Biotechnol (2010) 0.86
BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? Int J Biol Sci (2014) 0.84
Evolution of ligand specificity in vertebrate corticosteroid receptors. BMC Evol Biol (2011) 0.84
Chromatin context dominates estrogen regulation of pS2 gene expression. Exp Cell Res (2008) 0.83
Ecdysone induced gene expression is associated with acetylation of histone H3 lysine 23 in Drosophila melanogaster. PLoS One (2012) 0.82
Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation. Endocr Relat Cancer (2009) 0.82
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells. Antioxid Redox Signal (2014) 0.80
Ubiquitylation of nuclear receptors: new linkages and therapeutic implications. J Mol Endocrinol (2015) 0.79
Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cells. Oncotarget (2014) 0.79
Regulation of SIRT1 in vascular smooth muscle cells from streptozotocin-diabetic rats. PLoS One (2013) 0.78
DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers. Drug Des Devel Ther (2015) 0.78
Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase. Mol Cell Endocrinol (2011) 0.77
What's new in estrogen receptor action in the female reproductive tract. J Mol Endocrinol (2016) 0.77
Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent manner. J Biol Chem (2013) 0.76
Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes. J Biol Chem (2013) 0.76
LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP. Nucleic Acids Res (2016) 0.76
The role of circadian rhythm in breast cancer. Chin J Cancer Res (2013) 0.76
The Estrogen Receptor α-Cistrome Beyond Breast Cancer. Mol Endocrinol (2016) 0.76
Novel insights into the neuroendocrine control of inflammation: the role of GR and PARP1. Endocr Connect (2013) 0.76
Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer. Oncogene (2016) 0.75
Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study. Bosn J Basic Med Sci (2016) 0.75
Phosphorylation Alters Oestrogen Receptor β-Mediated Transcription in Neurones. J Neuroendocrinol (2015) 0.75
Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching. Genes Dev (2017) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 16.79
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J (2003) 11.27
CBP/p300 in cell growth, transformation, and development. Genes Dev (2000) 10.76
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
The Sir2 family of protein deacetylases. Annu Rev Biochem (2004) 9.28
Histone and chromatin cross-talk. Curr Opin Cell Biol (2003) 8.69
Histone modifications in transcriptional regulation. Curr Opin Genet Dev (2002) 8.10
Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev (1999) 7.42
Acetylation: a regulatory modification to rival phosphorylation? EMBO J (2000) 7.35
Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev (1999) 7.06
Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science (2001) 6.79
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell (1998) 6.62
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science (1997) 6.60
Mechanisms of estrogen action. Physiol Rev (2001) 5.97
Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell (1999) 5.23
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J (2002) 4.91
CREB-binding protein and p300 in transcriptional regulation. J Biol Chem (2001) 4.67
Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem (2002) 3.48
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A (2004) 3.06
p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev (1998) 2.96
The SRC family of nuclear receptor coactivators. Gene (2000) 2.96
The human histone deacetylase family. Exp Cell Res (2001) 2.86
Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol Cell Biol (1999) 2.80
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem (2005) 2.59
Histone deacetylases. Curr Opin Pharmacol (2003) 2.58
CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood (2000) 2.57
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A (1997) 2.49
Multisite protein modification and intramolecular signaling. Oncogene (2005) 2.42
Role of estrogen receptor beta in estrogen action. Annu Rev Physiol (2001) 2.40
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem (2000) 2.31
Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell (2002) 2.18
Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem (2001) 2.16
Mass spectrometric quantification of acetylation at specific lysines within the amino-terminal tail of histone H4. Anal Biochem (2003) 2.04
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology (2000) 1.98
Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem (2005) 1.93
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol (2003) 1.89
Regulating the regulators: lysine modifications make their mark. Cell (2003) 1.85
Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol (2005) 1.70
Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer (2003) 1.62
Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology (1999) 1.56
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol (2002) 1.48
Oestrogen receptors - an overview. J Intern Med (1999) 1.44
Rapidly switchable matrix-assisted laser desorption/ionization and electrospray quadrupole-time-of-flight mass spectrometry for protein identification. J Am Soc Mass Spectrom (2000) 1.42
Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology (1998) 1.36
Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci (2000) 1.35
p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol Cell Biol (2001) 1.34
Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem (2004) 1.33
Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J Biol Chem (2004) 1.33
A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31
Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene. Mol Endocrinol (1994) 1.27
Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. J Biol Chem (2003) 1.27
The estrogen receptor family. Curr Opin Obstet Gynecol (1999) 1.26
A role for coactivators and histone acetylation in estrogen receptor alpha-mediated transcription initiation. EMBO J (2001) 1.25
Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res (2005) 1.25
Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol Pharmacol (2000) 1.24
Chromatin assembly on plasmid DNA in vitro. Apparent spreading of nucleosome alignment from one region of pBR327 by histone H5. J Mol Biol (1991) 1.22
Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Mol Cell (2004) 1.08
Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? Eur J Biochem (2002) 1.08
Nuclear receptors, coactivators and chromatin: new approaches, new insights. Trends Endocrinol Metab (2001) 1.05
Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta. EMBO J (2003) 1.04
The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J Biol Chem (2004) 0.99
The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J Biol Chem (2002) 0.95
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2. J Steroid Biochem Mol Biol (2004) 0.94
Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. Mol Endocrinol (2005) 0.94
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. J Mol Endocrinol (2004) 0.91
Sirtuins for healthy neurons. Nat Genet (2005) 0.90
Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J Biol Chem (1999) 0.89
Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism. Steroids (2005) 0.86
The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell (2010) 5.06
Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev (2005) 4.61
A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell (2011) 4.42
NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell (2004) 4.21
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol (2012) 3.45
Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science (2008) 3.45
Enhancer transcripts mark active estrogen receptor binding sites. Genome Res (2013) 2.82
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev (2012) 2.82
Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc Natl Acad Sci U S A (2005) 2.40
Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol (2007) 2.33
Chromosomal enrichment and activation of the aurora B pathway are coupled to spatially regulate spindle assembly. Dev Cell (2007) 2.25
Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol Cell (2013) 2.13
Chromatin-bound Xenopus Dppa2 shapes the nucleus by locally inhibiting microtubule assembly. Dev Cell (2013) 2.09
PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell (2010) 2.06
Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc Natl Acad Sci U S A (2006) 1.95
Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes. J Mol Biol (2004) 1.87
The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev (2009) 1.82
The DNA binding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription. Mol Cell Biol (2007) 1.82
Regulation of class switch recombination and somatic mutation by AID phosphorylation. J Exp Med (2008) 1.78
Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol Cell Biol (2010) 1.75
Identification of SMARCAL1 as a component of the DNA damage response. J Biol Chem (2009) 1.74
Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem (2009) 1.70
Ku80 removal from DNA through double strand break-induced ubiquitylation. J Cell Biol (2008) 1.64
A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal (2008) 1.62
Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol Cell Biol (2008) 1.60
Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol Endocrinol (2007) 1.55
Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. J Biol Chem (2007) 1.53
The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction. J Biol Chem (2010) 1.47
SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta (2009) 1.41
Genomic analyses of hormone signaling and gene regulation. Annu Rev Physiol (2010) 1.38
Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. PLoS Genet (2011) 1.33
Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem (2009) 1.32
Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J (2006) 1.30
Multiple facets of the unique histone variant macroH2A: from genomics to cell biology. Cell Cycle (2010) 1.25
Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases. J Am Chem Soc (2010) 1.18
p300-mediated tax transactivation from recombinant chromatin: histone tail deletion mimics coactivator function. Mol Cell Biol (2002) 1.12
New functions for an ancient domain. Nat Struct Mol Biol (2009) 1.12
Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates. Mol Cell Biol (2003) 1.12
Transcriptional activation by nuclear receptors. Essays Biochem (2004) 1.10
Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Mol Cell (2004) 1.08
Histone H1 represses estrogen receptor alpha transcriptional activity by selectively inhibiting receptor-mediated transcription initiation. Mol Cell Biol (2002) 1.06
Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1. Proc Natl Acad Sci U S A (2005) 1.05
Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta. EMBO J (2003) 1.04
Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem Biophys Res Commun (2004) 1.03
Hormone-regulated transcriptomes: lessons learned from estrogen signaling pathways in breast cancer cells. Mol Cell Endocrinol (2013) 0.99
The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J Biol Chem (2004) 0.99
MYBBP1a is a novel repressor of NF-kappaB. J Mol Biol (2006) 0.99
From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease. Endocr Rev (2014) 0.98
PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2? Breast Cancer Res (2009) 0.95
A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex. Cancer Res (2010) 0.95
Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol Endocrinol (2011) 0.95
Regulation of chromatin structure and chromatin-dependent transcription by poly(ADP-ribose) polymerase-1: possible targets for drug-based therapies. Subcell Biochem (2007) 0.94
Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase. J Biol Chem (2012) 0.93
Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation. Mol Cell Biol (2010) 0.92
A novel Arabidopsis acetyltransferase interacts with the geminivirus movement protein NSP. Plant Cell (2003) 0.92
Small molecules, big effects: a role for chromatin-localized metabolite biosynthesis in gene regulation. Mol Cell (2011) 0.89
Promoter cleavage: a topoIIbeta and PARP-1 collaboration. Cell (2006) 0.89
Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. Mol Endocrinol (2003) 0.87
Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates. Prog Mol Biol Transl Sci (2009) 0.86
A one and a two … expanding roles for poly(ADP-ribose) polymerases in metabolism. Cell Metab (2011) 0.85
Evolution of ligand specificity in vertebrate corticosteroid receptors. BMC Evol Biol (2011) 0.84
Minireview: Long noncoding RNAs: new "links" between gene expression and cellular outcomes in endocrinology. Mol Endocrinol (2013) 0.83
Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors. Biotechnol Bioeng (2008) 0.82
Visualizing the histone code on LSD1. Cell (2007) 0.81
Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells. Mol Endocrinol (2012) 0.80
Mapping ERβ genomic binding sites reveals unique genomic features and identifies EBF1 as an ERβ interactor. PLoS One (2013) 0.80
From Discovery to Function: The Expanding Roles of Long Non-Coding RNAs in Physiology and Disease. Endocr Rev (2015) 0.78
Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase. Mol Cell Endocrinol (2011) 0.77
A PreSTIGEous use of LncRNAs to predict enhancers. Cell Cycle (2015) 0.75
Generation and Characterization of Recombinant Antibody-Like ADP-Ribose Binding Proteins. Biochemistry (2017) 0.75
Editorial: Centennial Celebration - A Focus on Endocrine Disrupting Chemicals… One Hundred Years in the Making. Mol Endocrinol (2016) 0.75